Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Jover Botella, A."'
Autor:
Jover Botella, A., Márquez Peiró, J.F., Márques, K., Monts Cambero, N., Selva Otaolaurruchi, J.
Publikováno v:
In Farmacia Hospitalaria 2011 35(1):8-13
Autor:
Jover Botella, A., Márquez Peiró, J.F., González Loreiro, M.D., Pitaluga Poveda, L., Selva Otaolaurruchi, J.
Publikováno v:
In Farmacia Hospitalaria (English Edition) 2011 35(1):28-31
Autor:
Jover Botella, A., Márquez Peiró, J.F., Márques, K., Monts Cambero, N., Selva Otaolaurruchi, J.
Publikováno v:
In Farmacia Hospitalaria (English Edition) 2011 35(1):8-13
Autor:
Ordovás Baines, Juan Pablo, Climent Grana, Eduardo, Jover Botella, Alejandro, Valero García, Isabel
Publikováno v:
In Farmacia Hospitalaria (English Edition) 2009 33(3):125-133
Autor:
A. Jover Botella, L. Pitaluga Poveda, M.D. González Loreiro, J. Selva Otaolaurruchi, J.F. Márquez Peiró
Publikováno v:
Farmacia Hospitalaria. 35:28-31
Objective: To assess the physical, chemical and microbiological stability of two oral suspensions of carbamazepine at concentrations of 2.5% and 5%.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa82dc6a838f0e4c8a83841ed96c3e1d
https://doi.org/10.1016/j.farma.2010.03.003
https://doi.org/10.1016/j.farma.2010.03.003
Autor:
M.D. González Loreiro, L. Pitaluga Poveda, J. Selva Otaolaurruchi, A. Jover Botella, J.F. Márquez Peiró
Publikováno v:
Farmacia Hospitalaria (English Edition). 35:28-31
Objective To assess the physical, chemical and microbiological stability of two oral suspensions of carbamazepine at concentrations of 2.5% and 5%. Methods Both oral suspensions were compounded from powdered carbamazepine and Ora-Sweet SF® and Ora-P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15c9204af4e6a3cf9bebf0d791a6cc98
https://doi.org/10.1016/s2173-5085(11)70005-3
https://doi.org/10.1016/s2173-5085(11)70005-3
Publikováno v:
Farmacia Hospitalaria (English Edition). 35:8-13
Objective To evaluate the effectiveness of 100% autologous serum eye drops for the treatment of various ocular surface disorders. Methods A descriptive prospective observational study carried out from May 2005 to February 2009 which included patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f51644593f2b37df16db4d5964208612
https://doi.org/10.1016/s2173-5085(11)70002-8
https://doi.org/10.1016/s2173-5085(11)70002-8
Publikováno v:
Farmacia Hospitalaria. 35:8-13
Objective: To evaluate the effectiveness of 100% autologous serum eye drops for the treatment of various ocular surface disorders. Methods: A descriptive prospective observational study carried out from May 2005 to February 2009 which included patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b929c408fbd47b24c0f2edf492d90500
https://doi.org/10.1016/j.farma.2010.02.004
https://doi.org/10.1016/j.farma.2010.02.004
Autor:
Alejandro Jover Botella, Eduardo Climent Grana, Juan Pablo Ordovás Baines, Isabel Valero García
Publikováno v:
Farmacia Hospitalaria. 33:125-133
Dabigatran is the fi rst available oral direct thrombin inhibitor anticoagulant. Absorption of the prodrug, dabigatran etexilate and its conversion to dabigatran is rapid (peak plasma concentrations are reached 4-6 hours following surgery, and a furt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dcbb096304665f178c62b9bf7491532
https://doi.org/10.1016/s1130-6343(09)71154-7
https://doi.org/10.1016/s1130-6343(09)71154-7
Autor:
Isabel Valero García, Alejandro Jover Botella, Eduardo Climent Grana, Juan Pablo Ordovás Baines
Publikováno v:
Farmacia Hospitalaria (English Edition). 33:125-133
Dabigatran is the first available oral direct thrombin inhibitor anticoagulant. Absorption of the prodrug, dabigatran etexilate and its conversion to dabigatran is rapid (peak plasma concentrations are reached 4–6 h following surgery, and a further
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b468ffb74e2b08411ecc1c49e6994928
https://doi.org/10.1016/s2173-5085(09)70078-4
https://doi.org/10.1016/s2173-5085(09)70078-4